Given their history of quarter cash flows, such an increase is not very significant. Not until they can show these increases are constant or increasing themselves.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025